Ключевые слова:
НАЖБП; фиброз печени; APOE; генетический полиморфизм; факторы риска.Библиографические ссылки
Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes // Hepatology. – 2016. – Vol. 64, No. 1. – P. 73–84.
Estes C., Razavi H., Loomba R., Younossi Z., Sanyal A.J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease // Journal of Hepatology. – 2018. – Vol. 67, No. 1. – P. 123–133.
Chalasani N., Younossi Z., Lavine J.E., Charlton M., Cusi K., Rinella M., Harrison S.A., Brunt E.M., Sanyal A.J. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the AASLD // Hepatology. – 2018. – Vol. 67, No. 1. – P. 328–357.
Fan J.G., Kim S.U., Wong V.W. New trends on obesity and NAFLD in Asia // Journal of Gastroenterology and Hepatology. – 2017. – Vol. 32, No. 1. – P. 53–62.
Ahmed A., Wong R.J., Harrison S.A. Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes // The Lancet Gastroenterology & Hepatology. – 2020. – Vol. 5, No. 5. – P. 425–436.
Angulo P. Nonalcoholic fatty liver disease // Gastroenterology. – 2007. – Vol. 132, No. 4. – P. 1797–1811.
Friedman S.L., Neuschwander-Tetri B.A., Rinella M., Sanyal A.J. Mechanisms of NAFLD development and therapeutic strategies // Nature Reviews Gastroenterology & Hepatology. – 2018. – Vol. 15, No. 11. – P. 667–685.
Dulai P.S., Singh S., Patel J., Soni M., Prokop L.J., Younossi Z., Sebastiani G., Ekstedt M., Hagström H., Nasr P., et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis // Hepatology. – 2017. – Vol. 65, No. 5. – P. 1557–1565.
Ekstedt M., Hagström H., Nasr P., Fredrikson M., Stål P., Kechagias S., Hultcrantz R. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up // Hepatology. – 2015. – Vol. 61, No. 5. – P. 1547–1554.
Pais R., Charlotte F., Fedchuk L., Bedossa P., Lebray P., Poynard T., Ratziu V. A systematic review of follow-up biopsies reveals disease progression in patients with nonalcoholic fatty liver // Clinical Research in Hepatology and Gastroenterology. – 2016. – Vol. 37, No. 4. – P. 406–414.
Tilg H., Moschen A.R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis // Gut. – 2010. – Vol. 59, No. 4. – P. 563–572.
Buzzetti E., Pinzani M., Tsochatzis E.A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) // Metabolism. – 2016. – Vol. 65, No. 8. – P. 1038–1048.
Anstee Q.M., Day C.P. The genetics of NAFLD // Nature Reviews Gastroenterology & Hepatology. – 2017. – Vol. 14, No. 10. – P. 645–657.
Romeo S., Kozlitina J., Xing C., Pertsemlidis A., Cox D., Pennacchio L.A., Boerwinkle E., Cohen J.C., Hobbs H.H. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease // Nature Genetics. – 2008. – Vol. 40, No. 12. – P. 1461–1465.
Kozlitina J., Smagris E., Stender S., Nordestgaard B.G., Zhou H.H., Tybjærg-Hansen A., Vogt T.F., Hobbs H.H., Cohen J.C. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease // Nature Genetics. – 2014. – Vol. 46, No. 4. – P. 352–356.
Buch S., Stickel F., Trépo E., Way M., Herrmann A., Nischalke H.D., Brosch M., Rosendahl J., Berg T., Ridinger M., et al. A genome-wide association study confirms PNPLA3 and identifies MBOAT7 as risk loci for liver fibrosis // Hepatology. – 2015. – Vol. 61, No. 5. – P. 156–166.
Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology // Journal of Lipid Research. – 1988. – Vol. 29, No. 4. – P. 495–517.
Getz G.S., Reardon C.A. Apolipoprotein E and inflammation in atherosclerosis // Arteriosclerosis, Thrombosis, and Vascular Biology. – 2018. – Vol. 38, No. 1. – P. 7–15.
Eichner J.E., Dunn S.T., Perveen G., Thompson D.M., Stewart K.E., Stroehla B.C. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review // American Journal of Epidemiology. – 2002. – Vol. 155, No. 6. – P. 487–495.
Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy // Physiological Reviews. – 2013. – Vol. 93, No. 3. – P. 1017–1045.
Rensen P.C., de Vrueh R.L., Kuiper J., Bijsterbosch M.K., Biessen E.A., Berkel T.J. Recombinant lipoproteins as carriers of drugs targeted to the liver // Journal of Hepatology. – 2001. – Vol. 34, No. 2. – P. 365–375.
Van den Elzen P., Garg S., León L., Brigl M., Leadbetter E.A., Gumperz J.E., Dascher C.C., Cheng T.Y., Sacks F.M., Illarionov P.A., et al. Apolipoprotein-mediated antigen presentation // Journal of Clinical Investigation. – 2005. – Vol. 115, No. 5. – P. 1317–1324.
Zhang H., Wu L.M., Wu J. Structural and functional characteristics of apolipoprotein E polymorphisms // Biochimica et Biophysica Acta. – 2011. – Vol. 1811, No. 11. – P. 735–742.
Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wiman B., de Faire U., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk // Atherosclerosis. – 2007. – Vol. 195, No. 2. – P. e96–e102.
Yu Y., Zhao Y., Teng F., Li J., Guan Y., Xu J., Chen J. Association between APOE polymorphisms and inflammatory markers // Cytokine. – 2014. – Vol. 67, No. 2. – P. 89–94.
Sookoian S., Pirola C.J. Genetics of nonalcoholic fatty liver disease: from pathogenesis to therapeutics // Clinical Liver Disease. – 2018. – Vol. 22, No. 1. – P. 59–73.
Eslam M., Valenti L., Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact // Journal of Hepatology. – 2018. – Vol. 68, No. 2. – P. 268–279.
Bedossa P. Pathology of non-alcoholic fatty liver disease // Seminars in Liver Disease. – 2015. – Vol. 35, No. 2. – P. 132–140.
Targher G., Byrne C.D., Lonardo A., Zoppini G., Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease // The Lancet. – 2018. – Vol. 392, No. 10165. – P. 1813–1824.
Loomba R., Schork N., Chen C.H., Bettencourt R., Bhatt A., Ang B., Nguyen P., Hernandez C., Richards L., Salotti J., et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study // Nature Reviews Gastroenterology & Hepatology. – 2021. – Vol. 18, No. 8. – P. 541–552.